OMERS Administration Corp’s State Street SPDR S&P Biotech ETF XBI Stock Holding History

OMERS Administration Corp’s Portfolio XBI Stock Details XBI Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q1	–	Sell	-1,190,707	Closed	-$145M	–	1182
2025 Q4	$145M	Buy	1,190,707 +1,187,907	+42,425%	+$136M	1.03%	32
2025 Q3	$281K	Buy	+2,800	New	+$252K	﹤0.01%	902
2025 Q2	–	Sell	-4,600	Closed	-$373K	–	1115
2025 Q1	$373K	Sell	4,600 -39,200	-89%	-$3.5M	﹤0.01%	813
2024 Q4	$3.95M	Buy	43,800 +12,900	+42%	+$1.25M	0.03%	188
2024 Q3	$3.05M	Buy	30,900 +12,100	+64%	+$1.19M	0.03%	262
2024 Q2	$1.74M	Sell	18,800 -65,200	-78%	-$5.85M	0.02%	420
2024 Q1	$7.98M	Buy	84,000 +67,800	+419%	+$6.29M	0.09%	92
2023 Q4	$1.45M	Buy	+16,200	New	+$1.2M	0.02%	135
2023 Q3	–	Sell	-43,000	Closed	-$3.58M	–	245
2023 Q2	$3.58M	Buy	+43,000	New	+$3.6M	0.06%	82

Other funds holding XBI

BNP Paribas Financial Markets Paris, France $206B AUM 31.61% 1-Year Est. Return

Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return

Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

Citigroup New York $235B AUM 32.99% 1-Year Est. Return

Healthcare of Ontario Pension Plan (HOOPP) Trust Fund Toronto, Ontario, Canada $62.2B AUM 31.35% 1-Year Est. Return

JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return

UBS Group Zurich, Switzerland $666B AUM 30.12% 1-Year Est. Return

Barclays London, United Kingdom $416B AUM 33.63% 1-Year Est. Return

Wells Fargo San Francisco, California $530B AUM 22.01% 1-Year Est. Return

OMERS Administration Corp's XBI Position: Q1 2026 in Review

OMERS Administration Corp sold out of State Street SPDR S&P Biotech ETF (XBI) in Q1 2026, closing a stake of 1,190,707 shares — an estimated $145M sold.

OMERS Administration Corp first reported a position in XBI in Q2 2023 and held it in 9 quarters. The position peaked at $145M in Q4 2025. 813 funds tracked by Wall St. Rank hold XBI as of Q1 2026.

OMERS Administration Corp reported no remaining State Street SPDR S&P Biotech ETF position as of Q1 2026 after selling out during the quarter.
OMERS Administration Corp sold 1,190,707 State Street SPDR S&P Biotech ETF shares in Q1 2026, an estimated $145M.
OMERS Administration Corp first reported a position in State Street SPDR S&P Biotech ETF in Q2 2023 and held it in 9 quarters.
OMERS Administration Corp's State Street SPDR S&P Biotech ETF position peaked at $145M in Q4 2025.
813 funds tracked by Wall St. Rank held State Street SPDR S&P Biotech ETF as of Q1 2026.

Based on OMERS Administration Corp's 13F filing for Q1 2026, filed 15 May 2026.